IN Ketamine vs IN Midazolam and Fentanyl for Laceration Repair
Brief Summary
Condition or Disease
- Laceration of Skin
Phase
Study Design
Study type: | Interventional |
---|---|
Status: | Recruiting |
Study results: | No Results Available |
Age: | 6 Months to 10 Years (Child) |
Enrollment: | 30 () |
Funded by: | Other |
Masking |
Clinical Trial Dates
Start date: | Sep 04, 2018 | |
---|---|---|
Primary Completion: | Feb 21, 2020 | |
Completion Date: | Sep 15, 2021 | |
Study First Posted: | May 18, 2018 | |
Results First Posted: | Aug 31, 2020 | |
Last Updated: | Jul 31, 2020 |
Sponsors / Collaborators
Location
Children frequently present to pediatric emergency center (PEC) with cuts of different body parts. Often, repair of the cuts (laceration repair) proves to be traumatic for the children and the parents alike. Ideally, repair of the cuts should be as painless and free from anxiety as possible. To work towards this goal, different analgesic (pain drugs) and sedative ( to calm patients down) management strategies use intravenous (into the vein), intramuscular ( into the muscle) and, more recently, intranasal (into the nostrils) routes. Unfortunately, intravenous access is hard to establish and may be painful for the child. The intramuscular route is often similarly painful. Due to the rich blood supply and large surface area of the nasal vestibule, intranasally (IN) administered medications are highly absorbed. IN approaches for procedural pain reduction, such as during dental work, have been demonstrated to make drug administration painless and well tolerated, making it an attractive potential alternative to commonly used intravenous and intramuscular approaches. In several small research studies, high doses of intranasal ketamine (9 mg/kg) produce adequate sedation during laceration repair with minimal side effects. A recent study compared IN ketamine, midazolam, fentanyl or combination of these drugs for pain management and urgent analgesia sedation, and demonstrated that they are effective and safe, reporting that ~60% of study participants sustained mild to moderate sedation. Unfortunately, there are not enough studies done to evaluate the sedation effect of IN ketamine for laceration repair. Small studies (Tsze and Nemeth) showed that IN ketamine is an effective alternative but no studies are done to compare combination IN midazolam and fentanyl to IN ketamine. Our null hypothesis is that there is no difference in sedation scores during laceration repair when comparing the use of IN ketamine to IN midazolam and IN fentanyl.
We will recruit a total of 30 pediatric patients (6 months - 10 y age) in a randomized double-blinded pilot study of IN ketamine alone or combined IN midazolam and IN fentanyl for laceration repair, comparing levels of pain and sedation scores using validated pediatric metrics as the primary outcomes. In addition, we will assess comparative nurse and physician satisfaction in each of these two groups. Understanding the relative effectiveness of these two approaches will help us identify a safe, effective, and easily administrable method to manage pain and anxiety, thereby, improving patient experience and outcomes during the often traumatic laceration repair procedure.
Eligibility Criteria
Sex: | All |
---|---|
Maximum Age: | 10 |
This clinical trial is recruiting
Are you interested in participating in this trial or others? We'd love to help.
More Details
NCT Number: | NCT03528512 |
---|---|
Other IDs: | 2017-363 |
Study URL: | https://ClinicalTrials.gov/show/NCT03528512 |